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Abstract. The increasing and unprecedented publication rate in the biomedical field is a major bottleneck for 
knowledge discovery in the Life Sciences. The manual curation of facts from published scientific papers is slow 
and inefficient, and therefore new approaches are needed that can enable the automatic, scalable and reliable 
extraction of assertions. While the publication of scientific assertions and datasets on the Semantic Web is gaining 
traction, it also creates new challenges such as the proper representation of provenance and versioning. Here, we 
address these issues and describe our efforts to represent the DisGeNET database of human gene-disease 
associations as permanent, immutable, and provenance rich digital objects called nanopublications. Our 
nanopublications are the first instance of a Linked Data model that ensures stable interlinking of the assertion and 
its metadata by Trusty URIs. As DisGeNET integrates manually curated as well as text-mined data of different 
origins, the semantic description of the evidence for each assertion is important to provide trust and allow 
evidence-based hypothesis generation. Here, we describe our steps to ensure high quality and demonstrate the 
utility of linking our data to other datasets on the emerging Semantic Web. 
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1. Introduction 
To obtain a deeper understanding of the molecular 
mechanisms of diseases and to support drug 
development and healthcare research, biomedical 
researchers need to explore the current knowledge on 
the complex relationships between genes, proteins, 
gene variants, pathways, drugs, phenotypes and 
environmental factors. Scientific knowledge is 
mainly communicated and gathered as scholarly 
publications. To ease the access and exploitation of 
this knowledge, one of the main strategies is to 
manually extract and curate biomedical statements 
from the literature and structure them in databases.  
Due to the increasing size of literature repositories 
and the number of different dispersed and isolated 
databases, there are many efforts devoted to 
efficiently extract and provide the most up-to-date 
data in a way that can be integrated with existing 
datasets to facilitate knowledge discovery. These 
efforts include a) text mining approaches aimed at 
extracting relationships between biomedical entities 
from the literature [10], b) community-driven 
publication approaches based on wiki systems [6-7, 
22], c) the publication of existing databases to the 
Linked Open Data cloud (LOD)
1
 (UniProt [24], 
DisGeNET [13]), and d) ambitious projects like the 
publication of entire Linked Data networks such as 
Bio2RDF [3] and Linked Life Data
2
.  
DisGeNET is a discovery platform developed in 
the Integrative Biomedical Informatics (IBI) group 
designed to enable research on the genetic basis of 
the pathophysiology of diseases. The platform offers 
one of the most comprehensive collections of 
knowledge on human gene-disease associations 
(GDAs) integrating over 380,000 associations 
between more than 16,000 genes and 13,000 diseases 
covering all disease areas. These GDAs are collected 
from seven different public databases, which include 
human and animal model expert-curated databases. 
DisGeNET also includes GDAs extracted from 
MEDLINE by the BeFree [2] NLP-based approach. 
All these data are integrated, harmonized and made 
accessible for exploration and analysis through a 
Web interface, a Cytoscape plugin [1], and as an 
RDF linked dataset [17] with an open license. 
The Semantic Web enables data integration and 
interoperability, but new challenges emerge when the 
data are used for the identification and evaluation of 
scientific hypotheses. These challenges include the 
tracking of provenance to understand the basis of an 
assertion and its relation to existing evidence, and the 
creation of unambiguous references to immutable 
scientific assertions. To overcome these issues we 
publish our DisGeNET GDAs as a new linked RDF 
dataset using the emerging nanopublication 
approach
3
 and the Trusty URI technique [23]. The 
nanopublication approach is a community-driven 
effort that proposes a publishing model based on 
minimal scientific statements along with their 
provenance and associated context. A 
nanopublication is formally defined using Semantic 
Web standards - the W3C’s Resource Description 
Framework (RDF) and the Web Ontology Language 
(OWL) - and the nanopublication schema
4
. 
Specifically, it consists of three named RDF graphs 
(excluding the head graph) representing the assertion, 
its provenance and metadata about the 
nanopublication itself using resolvable Uniform 
Resource Identifiers (URIs). Consequently, standard 
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RDF technologies, such as triple stores and SPARQL 
query engines, can be used to retrieve and analyze 
nanopublications through the Web, and to support 
automatic reasoning. 
The linked dataset presented here is the first 
database published as nanopublications using Trusty 
URIs. Trusty URIs use cryptographic hash values to 
generate unique and stable identifiers based on their 
content. This makes digital artifacts identified using 
Trusty URIs permanent, immutable, and verifiable. 
Converting a dataset into nanopublications with 
Trusty URIs enables users and software agents to 
trace and interpret how a statement was produced, 
ensuring reproducibility, reliability, and enhancing 
citation. Another advantage is that both the scientific 
assertions and their metadata are interoperable, 
shareable, reusable, and supports discoverability by 
provenance-aware applications. 
In this paper, we present the DisGeNET 
Nanopublications linked dataset as an alternative way 
to disseminate the information contained in 
DisGeNET. The conversion into nanopublications 
presented in this paper aims to extend and 
complement the capabilities of the existing 
DisGeNET dataset in RDF. The goal is to foster the 
publication and discoverability of these assertions, to 
support the automated aggregation of their evidence 
levels, and to support the generation of evidence-
based new hypotheses in the biomedical field.  
2. Gene-Disease Associations in DisGeNET 
In order to cover different aspects of gene-disease 
relations, DisGeNET GDA content is extracted from 
various types of sources ranging from structured 
databases on human and animal models to 
unstructured scientific literature. DisGeNET provides 
evidence-based classifications of the data according 
to the level and type of curation in the original 
databases that enable users to rapidly assess the 
quality of the specific GDA. The DisGeNET 
evidence classes are: “CURATED” for human GDAs 
that are reviewed by experts, “PREDICTED” for 
human GDAs inferred from the GDA of an animal 
model that was reviewed by an expert, and 
“LITERATURE” for human GDAs that were 
automatically extracted from the literature by text 
mining methods (see DisGeNET coverage in Table 
1). It is important to point out that DisGeNET not 
only aggregates GDA statements from different 
sources, but integrates them in a uniform way 
accompanied with contextual annotation. Specifically, 
the provenance and evidence are well described and 
fine-grained for each statement in order to keep track 
of them after integration. DisGeNET GDA content is 
represented according to various structured data 
model conventions: as a relational database, as an 
RDF linked dataset, and now as a nanopublication 
linked dataset. In the following sections, we first 
describe the RDF linked dataset version of 
DisGeNET data, followed by a description of the 
DisGeNET nanopublication set and methods to 
querying them, concluding with possible applications 
and related work. 
 
 
Table 1 
The DisGeNET evidence classification and its coverage in the 
nanopublication dataset. 
RDF Predicate ECO Class DisGeNET 
Evidence (%) 
Assertion Type   
<wi:evidence>  ECO_0000205 CURATED (4) 
 ECO_0000266 PREDICTED (1) 
 ECO_0000212 LITERATURE (95) 
Assertion Method   
<prov:wasGeneratedBy>  ECO_0000218 MANUAL 
 ECO_0000203 AUTOMATIC 
 
2.1. RDF Dataset Description 
There are three main components in the RDF 
dataset: GDA content, provenance description of the 
RDF dataset, and linksets to other linked datasets. 
Each of these components is described separately in 
the following sections. 
2.1.1. GDA Content 
The RDF representation identifies genes by their 
NCBI Gene ID and diseases by their UMLS Concept 
Unique Identifier (CUI), and captures the biological 
type of the association. The gene and the disease 
additionally have different annotated attributes (see 
the schema at http://rdf.disgenet.org/). Entities and 
properties are semantically annotated using standard 
ontologies such as the NCI thesaurus (NCIt)
5
, and 
resources are identified by using dereferenceable 
URIs. GDAs are integrated using the DisGeNET 
association type ontology, which is an ontology 
developed in the IBI group to fill the gap in formal 
semantics for the definition of types of associations 
between a gene and a disease in biological databases. 
This ontology is based on the description of the GDA 
 
5  http://ncit.nci.nih.gov/ 
association type in the original databases. The 
DisGeNET ontology is integrated into the 
Sematicscience Integrated Ontology (SIO) [15], 
which is an OWL ontology that provides basic types 
and relations for the description of objects, processes 
and their attributes, so that GDAs in RDF are 
semantically harmonized using SIO classes. A 
normalized dereferenceable URI scheme for the 
identification of GDA entities is implemented using 
“http://rdf.disgenet.org/” as namespace. 
2.1.2. Provenance 
A full provenance description of the RDF linked 
dataset is provided using the Vocabulary of 
Interlinked Datasets (VoID)
 6
, a recommended 
standard for expressing metadata about RDF datasets. 
This description includes the provenance of 
DisGeNET's relational database, its primary 
databases, and the BeFree text mining approach. The 
type of curation and level of evidence of each 
original database is also tracked and annotated. Each 
data instance in the DisGeNET RDF dataset is 
explicitly linked to this provenance description in 
order to granulate and trace back the provenance to 
the instance level (access to the VoID.ttl file 
description at http://rdf.disgenet.org/ Web site). 
2.1.3. Interlinking 
DisGeNET data is linked to LOD in order to both 
enrich GDAs with annotations from external 
Semantic Web resources and expand the GDA 
content in the Semantic Web in a metadata-aware 
manner. 4,962,315 links to LOD through projects 
such as Bio2RDF and Linked Life Data, exist in the 
current version. All entities are linked using the same 
SKOS
7
 predicate skos:exactMatch. The interlinking 
is derived from the cross-references provided by the 
source databases and ontologies. These cross-
references were extracted with in-house scripts and 
were used for manual interlinking to different data 
sources. Other linkset statistics between entities can 
be found on DataHub
8
. 
3. DisGeNET Nanopublication Dataset 
As conforming to the nanopublication standard, 
our DisGeNET nanopublications consist of four 
named graphs: head, assertion, provenance and 
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publication information (Figure 1). The head graph 
defines the structure of the nanopublication by 
linking to the other nanopublication graph URIs. The 
assertion graph contains the description for a specific 
single GDA assertion. The provenance graph 
includes provenance, evidence and attribution 
statements that were directly mapped from the VoID 
description of the RDF dataset. Finally, the 
publication information graph includes all the 
metadata information regarding the nanopublication 
itself. We also include in this graph a description of 
the general topic of the nanopublication to enhance 
discoverability. The general topic of our 
nanopublications is ‘Gene-Disease Association’, and 
each nanopublication is annotated using the Dublin 
Core vocabulary (DC)
9
 object property ‘subject’ to 
the SIO concept ‘SIO_000983’, which represents the 
‘gene-disease association’ concept. The 
nanopublication dataset is a linked dataset as all 
resources are identified and linked to other linked 
datasets using dereferenceable URIs, and gene and 
disease entities are identified by URIs constructed on 
widely adopted namespaces, such as identifiers.org 
[16] to enable interoperability and query federation. 
Importantly, the nanopublication URIs are trusty, i.e. 
they are generated by applying the Trusty URI 
approach to guarantee the integrity of the 
nanopublication content and ensure its immutability, 
reliability, and verifiability for scientific citation. 
 
3.1. Ontologies 
For modeling our nanopublications, we needed to 
determine what information to include, how to 
formally represent it, and which ontologies to use to 
best represent the semantics. To represent the GDAs 
in the assertion part of the nanopublications, we used 
the same triples and ontologies already present in the 
RDF version of our data. That is, we use SIO to 
encode both the type of association and to relate the 
disease and the gene associated, and NCIt to encode 
the gene and disease biomedical entity types. 
 
 
9  http://dublincore.org/ 
 
Fig. 1: DisGeNET nanopublication schema. See an example in 
RDF/TriG notation at our Web site10. 
 
One important step in the nanopublication 
modeling was to find appropriate vocabularies for the 
description of the provenance and metadata in the 
nanopublication graphs. To represent provenance 
information we mainly used the PROV Ontology 
(PROV-O)
11
, which is a W3C recommended standard 
as a general high-level model for provenance. It 
provides well-defined upper-level classes, 
relationships and restrictions to frame any kind of 
provenance. For authorship, versioning, and content 
creation we used the Provenance, Authoring and 
Versioning (PAV) vocabulary [18], and for Web data 
we used the Provenance Vocabulary Core Ontology 
Specification (PRV)
12
, which are both extensions of 
the PROV ontology that allow for more explicit 
representations of the data. Finally, DC terms are 
used for general metadata. The evidence annotation 
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is formally described using the Weighted Interests 
vocabulary (WI)
13
, which provides a suitable object 
property wi:evidence that links the assertion with its 
evidence, and the Evidence Codes Ontology (ECO)
14
, 
which provides suitable classes to represent the 
meaning of the DisGeNET evidence classes (Table 1). 
It is not always straightforward to find ontologies 
that are semantically compatible with our 
requirements and existing data, e.g. it was not 
possible to establish perfect equivalence between our 
evidence classes and ECO classes. Platforms such as 
the NCBO Bioportal
15
, Ontology Lookup Service
16
, 
or the NCBO Annotator
15
 ease this task. Even though 
the modeling in the Semantic Web offers the freedom 
to make any decision necessary to best describe the 
data, it is a good practice to use commonly used 
vocabularies. With this in mind, we chose the ECO 
and WI ontologies since they are already in use to 
model neXtProt evidence [8-9]. 
A summary of the Linked Data vocabularies used 
in DisGeNET nanopublications is shown in Table 2. 
We published our dereferenceable nanopublications 
on the Web with a human-readable list of the 
vocabularies. The SIO and ECO ontology concepts 
are deployed in our triple store to be available both as 
machine-readable explicitly at axiom level to 
optimize the GDAs searches in our SPARQL 
endpoint, and to be human-readable in our Linked 
Data Faceted Browser. 
 
3.2. Schema 
Here we present the first version of the 
nanopublication model for DisGeNET data, which is 
based on the official nanopublications guidelines
4
 
(accessed during summer of 2014). It is worth 
mentioning that other nanopublications were used as 
templates (examples accessed at nanopub.org, 
neXtProt nanopublications [8-9], BEL2nanopub 
approach
17
) to facilitate the process of modeling. 
Moreover, the reuse of templates fosters a natural 
creation of best practices both for RDF triple 
description of information and for vocabularies 
adoption and, consequently, enhances 
interoperability of scientific results [11].  
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The assertion graph states the gene and the disease 
involved in the association, each identified by 
existing well-defined URIs. It also states the type of 
GDA as asserted by the authors of the statement. 
This is annotated using SIO, which it provides formal 
semantics for representing GDA entities. For 
example, it is possible to explicitly model the 
relationships between the gene and the disease in the 
association as ‘gene-disease association linked with 
altered gene expression’. The provenance graph 
includes provenance and attribution information 
directly linked to the assertion such as the scientific 
article as the primary evidence, the source database 
from which it was derived and the derivation date for 
the first stage of annotation. The method of 
extraction of the assertion is also included, i.e. 
whether the statement was manually or automatically 
asserted. The level of evidence of each assertion is 
annotated using the DisGeNET evidence 
classification, a classification system used in the 
context of DisGeNET, similar to those used in other 
databases such as the quality assessment 
classification system in neXtProt [8-9]. We minted 
the DisGeNET evidence concepts using the 
DisGeNET RDF namespace (http://rdf.disgenet.org) 
as a base. This is a temporary solution as, in order to 
make our nanopublications more discoverable for 
aggregation of evidence, we are planning to use the 
ConceptWiki
18
 to add URLs to the DisGeNET 
evidence concepts. Additionally, a human readable 
description of the assertion extracted from the 
attributed sources is added. Finally, the publication 
information graph includes all the metadata 
information regarding the nanopublication itself such 
as when it was made by date/time stamp, copyright 
information to inform how the nanopublication can 
be reused, the version of the nanopublication, the 
RDF Linked Data version used to produce it, and its 
authors and creators. These attribution statements use 
object properties referring to unique digital 
identifiers that represent researchers, e.g. ORCID 
identifiers.
 
18  http://www.conceptwiki.org/ 
Table 2 
Vocabularies prefixes, namespaces and topics used in DisGeNET nanopublications. 
Prefix Namespace Topic 
np http://www.nanopub.org/nschema# Nanopublication  
rdfs  http://www.w3.org/2000/01/rdf-schema# RDF 
xsd http://www.w3.org/2001/XMLSchema#  XML 
sio http://semanticscience.org/resource/  General science 
ncit http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl# Biomedical 
lld http://linkedlifedata.com/resource/umls/id/ Linked Life Data 
miriam-gene http://identifiers.org/ncbigene/  Identi fiers.org/NCBI Gene 
miriam-pubmed http://identifiers.org/pubmed/ Identi fiers.org/PubMed  
eco http://purl.obolibrary.org/obo/eco.owl# Evidence codes 
wi http://purl.org/ontology/wi/core# Preferences in context 
prov http://www.w3.org/ns/prov# General provenance 
pav http://purl.org/pav/2.0/ Provenance, authoring, versioning 
prv http://purl.org/net/provenance/ns# Provenance of Web data 
dcterms  http://purl.org/dc/terms/ General metadata 
  
 
3.3. Availability, Production and Sustainability 
We present here the first release of DisGeNET 
published as nanopublications, which corresponds to 
version v2.1.0.0. The dataset consists of 940,034 
nanopublications, representing the same number of 
scientific assertions for 381,056 different GDAs with 
their detailed provenance, levels of evidence and 
publication information descriptions. In total this 
represents 3,760,136 annotated RDF nanopublication 
graphs. Specifically, the dataset is composed of 
31,961,156 quads, i.e. RDF triples with their graph 
(or “context”) added as the fourth member in the 
tuple (Subject, Predicate, Object, Context), 
everything being serialized using the TriG syntax
19
. 
DisGeNET nanopublications can be accessed in three 
ways: as a file in TriG format that can be 
downloaded, by navigating using our Faceted 
Browser, or by querying our SPARQL endpoint (see 
http://rdf.disgenet.org/). The dataset is made 
available under the Open Database License terms 
whose full text can be found at 
http://opendatacommons.org/licenses/odbl/1.0/. 
The generation of our nanopublications started 
from the relational database whose data are used to 
produce the RDF linked dataset. This RDF dataset is 
generated by in-house scripts that prepare data for the 
D2RQ platform
20
, which is the software that 
serializes relational data into RDF/Turtle. 
Nanopublications are derived from the RDF graph 
linked dataset representation. Both DisGeNET linked 
datasets are stored and available to query in the  
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Virtuoso
21
 SPARQL endpoint. We would like to 
generate the DisGeNET nanopublications via 
SPARQL INSERT/CONSTRUCT queries over the 
RDF dataset, but this is currently not possible for 
technical limitations of the Virtuoso SPARQL server. 
To bypass this issue, we developed custom scripts to 
construct and serialize our nanopublications in the 
recommended TriG syntax directly from our 
relational data. While, on the one hand, this solution 
may be a source of production errors, it may foster a 
future base of more mature scripts forming a 
sustainable pipeline to produce DisGeNET 
nanopublications on a regular basis , and for sharing 
them with the community through systems as 
GitHub
22
.  
The nanopublication dataset will be updated 
accordingly in conjunction with its parent relational 
and RDF versions. Two major updates per year are 
envisioned for the relational database and 
consequently the RDF Linked Data distribution, 
therefore these updates may well also affect the 
nanopublication content. In addition, the maintenance 
of the nanopublication dataset may require additional 
new versions. In each major revision of DisGeNET 
we include more data sources into the database to 
increase the coverage on the current knowledge in 
GDAs, and new annotations, adding more value to 
the data. For example, in the last update we included 
new and popular expert-curated datasets: RGD, CTD 
mouse, CTD rat and our literature-mined BeFree 
dataset, as well as new annotations describing the 
level of evidence of each data source. These new 
evidence codes are highlighted in Table 1. The 
versioning for nanopublications consists of keeping 
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track of the provenance of both the RDF and the 
relational version of DisGeNET data from which the 
RDF is derived. Thus, the nanopublication version 
information is a composite of: the version of the 
relational database (v2.1) plus the version of the RDF 
dataset (v2.1.0) plus the version of the 
nanopublication (v0). Finally, in recognition of the 
interest in the nanopublishing of DisGeNET GDAs, 
we note that from the day we made it available in the 
download section of our Web site (October 13rd, 
2014) until January 26th, 2015, the nanopublication 
dataset has been downloaded 52 times while the RDF 
has been downloaded 43 times. 
4. Querying DisGeNET Nanopublications 
With the aim to show the questions that can be 
answered by our nanopublication implementation, we 
use the following question as an example: What are 
the proteins (and their protein interactions) 
associated to Prostatic Neoplasms with curated 
evidence? The query in Figure 2 illustrates how to 
retrieve this information. First, we ask for 
nanopublications (?nanopub) but only pointing at 
their assertion and provenance graphs (Selecting 
Nanopublication Content by Graph) . Second, we 
query DisGeNET for all the genes associated to 
Prostatic Neoplasms. To retrieve these data we need 
to query the assertion graph (?assertion), where we 
ask for gene-disease associations (?gda) where the 
disease involved in the association is identified by 
the CUI ‘C0033578’ (Retrieving Gene-Disease 
Associations). Third, we filter the prior results with 
those assertions annotated as curated in DisGeNET 
(?evidence). This query part involves the provenance 
graph (?provenance) (Filtering By Evidence). Finally, 
we link these results to the Interaction Reference 
Index database [20], which contains PPI annotations, 
through the Bio2RDF::irefindex SPARQL endpoint, 
thereby federating the query (Linking with Other 
LOD Resources). Since our RDF data annotates each 
gene with the protein(s) that it encodes, we are able 
to link DisGeNET to Bio2RDF::irefindex by Protein 
resources. To retrieve proteins from DisGeNET we 
query the RDF graph (http://rdf.disgenet.org). Then, 
we link these protein resources in DisGeNET to 
protein resources in Bio2RDF through the 
corresponding linkset to 
<http://bio2rdf.org/uniprot:uniprotID>. To answer 
this question, we have retrieved data querying 
different graphs: head, assertion and provenance 
graphs in each nanopublication, the DisGeNET-RDF 
graph, and the iRefIndex graph. 
 
 
 
 
 
Fig. 2: An example of SPARQL query. 
 5. Applications 
We aim to incorporate the DisGeNET GDA 
collection in knowledge discovery projects such as 
the Open PHACTS Discovery platform [4]. The 
Open Pharmacological Concepts Triple Store project 
(Open PHACTS) has developed a powerful cloud-
based platform for open access data following a 
Semantic Web approach that allows scientists to 
draw on diverse databases to answer many questions 
relating to drug discovery. The new version of the 
platform will integrate and provide access to 
additional datasets such as WikiPathways [22], 
neXtProt, which was also recently converted into 
nanopublications, and DisGeNET. 
6. Related Work 
A variety of datasets represented as 
nanopublications have recently been published. Beck 
et al. [21] provided a nanopublication dataset on 
comprehensive genome-wide association studies 
(GWAS) to organize and annotate the complex 
spectrum of observed human GWAS phenotypes for 
reuse and interchange, to assist with cross-species 
genotype and phenotype comparisons, and to 
integrate GWAS data into the Linked Data Web.  
This work underlined the importance of including 
appropriate provenance and context information to 
avoid confusion to data consumers since their GWAS 
nanopublications are simply items of data not yet 
validated, i.e. not established facts.  Chichester et al. 
[9] explored the use of neXtProt nanopublications to 
obtain new insights based on restricted levels of 
evidence related to sequence variation, expression, 
and regulation of human proteins important for 
precision medicine. Mina et al. [11] used the 
nanopublication model to expose different assertions 
generated by a Taverna workflow analysis applied to 
the investigation of the relation between 
Huntington’s Disease genes and epigenetic regulation. 
They showed the potential of the model to provide 
metadata from a computational analysis, which will 
enable reproducibility and increase trust in the 
assertions. They also showed that the 
nanopublication model enables the connection of this 
information to the Research Object model [14]. In 
Sernadela et al. [19], the authors explored the 
nanopublication integration of large collections of 
annotated associations between drugs and their 
adverse events extracted by data mining techniques 
and applied to pharmacovigilance, and present three 
interoperable data exchange interfaces. Recently, two 
novel examples of using nanopublications to track 
and aggregate evidence for future applications on 
knowledge discovery and evidence-based decision 
making processes have appeared. The Repurposing 
Drugs with Semantics (ReDrugS) framework [12], 
based on a systems biology approach, represents 
biological and chemical entity interactions contained 
in databases as nanopublications including 
descriptions of the experimental methods used to 
derive the assertions. By creating consensus 
assertions, they assign a combined probability of 
truth inferred from those experimental methods. They 
showcased their approach by searching and 
discovering new drug-gene associations for drug 
repurposing based on statistical aggregation of 
confidence. Another relevant pioneering work [5] 
proposes to track the provenance information in 
diagnostic databases and diagnostic processes by a 
nanopublication approach, with the goal to enable 
accurate and evidence-based clinical decision making. 
7. Summary 
We have created a nanopublication-based linked 
dataset that provides 940,034 nanopublications  on 
scientific statements of human GDAs. These GDAs 
identified by Trusty URIs are machine-interpretable, 
immutable, permanent, and verifiable, which 
promotes data citations and stable references. Each 
GDA statement has its provenance description 
providing attribution, creation time, and further 
context of its creation to confer trust. Each GDA is 
classified as “CURATED”, “PREDICTED”, or 
“LITERATURE” to categorize the evidence of the 
statement based on the type of assertion and curation 
made in the original databases. We have enriched the 
provenance annotation by stating the type of curation 
of the assertion, and classified the nanopublications 
by their level of evidence. DisGeNET 
nanopublications include metadata annotations about 
the general topic of the nanopublications, i.e. ‘Gene-
Disease Association’, semantically described by SIO 
to ease their discoverability in the Semantic Web. 
With an illustrative use case we show how our 
nanopublications can be used to explore GDAs and 
how they can be integrated with relationships 
published in other LOD sources, which to permit data 
integration across domains. 
The publication of our DisGeNET nanopublications 
on the Web of Data will enable a large-scale 
interconnection of statements about genes and 
diseases and will allow users to explore them based 
on evidence. This is essential for knowledge 
discovery, and our approach can help to get a better 
picture of the molecular basis of pathological 
conditions. 
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